| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | glutamic acid | 7289 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 11521 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 13577 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 14859 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 26366 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 31071 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 35020 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 36149 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 49182 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 50051 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 66045 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 66825 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 70936 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 73958 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 74176 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 85732 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 89371 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 102141 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 102171 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 106293 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | glutamic acid | 111936 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 116213 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 116287 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 125912 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 127442 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 128636 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 131414 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 131989 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 133765 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 137109 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 140491 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 140581 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 141200 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 141215 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 144976 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 145002 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | glutamic acid | 149529 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 150821 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 151175 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 157222 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glutamic acid | 159481 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 165295 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 197263 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 202210 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 205300 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 206914 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 218545 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 241842 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glutamic acid | 249703 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | glutamic acid | 251861 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 264078 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glutamic acid | 311417 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 819102 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glutamic acid | 858050 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|